ASAM, working with the Partnership to Amend 42 CFR PArt 2, sent a letter urging lawmakers to align 42 CFR Part 2 with the Health Insurance Portability and Accountability Act (HIPAA)

ASAM applauds the introduction of the Cannabidiol and Marijuana Research Expansion Act, which would enable researchers to better study cannabis.

The Opioid Workforce Act of 2019 (H.R. 3414), introduced by Representatives Brad Schneider (D-IL), Susan Brooks (R-IN), Ann Kuster (D-NH), and Elise Stefanik (R-NY), would help address the national shortage of addiction physician specialists by increasing the number of resident physician positions available in hospitals that either have or are developing residency programs in addiction psychiatry or addiction medicine (or pain medicine).

Yngvild Olsen, MD, MPH urged lawmakers to expand access to evidence-based addiction treatment and invest more resources to address the addiction and overdose crisis during today’s House Committee on Oversight and Reform Hearing .

ASAM signed onto a letter commenting on the Tobacco to 21 Act, the Reversing the Youth Tobacco Epidemic Act, and the Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019.

ASAM urges Congress to make significant improvements to MACRA.

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to use the Lower Health Care Costs Act of 2019 as an opportunity to align 42 CFR Part 2 with HIPAA.

ASAM took the opportunity to advocate for standardization of addiction treatment when MACPAC released its request for information on the Medicaid IMD Additional INFO Act.